About PMV Pharmaceuticals Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.pmvpharma.com/
Frequently Asked Questions
What is the 52-week range for PMVP?
The 52-week high is $1.91 and the 52-week low is $1.02.
What is the P/E ratio for PMVP?
The P/E ratio data is currently unavailable.
What is the dividend yield for PMVP?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -78.11%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.64.
Analyst Recommendation Trends
Wall Street analyst consensus for PMVP over the last few months:
Latest PMVP News
These Biotech Stocks Are Cheap Based On 1 Fundamental Measure
Biotech stocks can offer high reward opportunities. Here are three North American biotech stocks that could offer both growth and value.
Should You Buy PMV Pharmaceuticals, Inc. (PMVP) After Golden Cross?
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer
Commercial leadership appointment supports launch preparation for rezatapopt Company planning NDA submission for accelerated approval of rezatapopt in patients with platinum-resistant/refractory ovarian cancer in first quarter of 2027 PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today announced the appoint
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-06-04 | FLOWERS KIRSTEN | +42,000 | - | - |
| 2026-06-04 | Stelzer Laurie | +42,000 | - | - |
| 2026-06-04 | BAUM CHARLES M | +42,000 | - | - |
| 2026-06-04 | Gallagher Carol Giltner | +42,000 | - | - |
| 2026-06-04 | Gallagher Carol Giltner | -42,000 | - | - |
| 2026-06-04 | Gallagher Carol Giltner | +42,000 | - | - |
| 2026-06-04 | LEVINE ARNOLD J | +42,000 | - | - |
| 2026-03-05 | Carulli Michael | +240,000 | - | - |
| 2026-03-05 | Jalota Deepika | +303,310 | - | - |
| 2026-03-05 | Ticktin Robert | +319,270 | - | - |
| 2026-03-05 | Mack David Henry | +744,960 | - | - |
| 2025-10-27 | Mack David Henry | -220,643 | - | - |
| 2025-10-27 | Mack David Henry | +220,643 | $1.37 | $302,281 |
| 2025-10-23 | ORBIMED ADVISORS LLC | -1,000,000 | $1.52 | $1,520,000 |